# DESCRIPTION

## FIELD OF INVENTION

- introduce immunogenic polypeptides

## GENERAL BACKGROUND

- describe Chlamydia diseases
- discuss limitations of current treatments
- motivate need for Chlamydia vaccine
- summarize past vaccine development efforts
- discuss importance of immunogenic molecules

## SUMMARY OF THE INVENTION

- introduce polypeptide-based vaccine

## DETAILED DISCLOSURE OF THE INVENTION

- disclose Chlamydia antigens for pharmaceutical composition
- disclose specific peptide fragments for pharmaceutical composition
- disclose pharmaceutical composition and its uses
- disclose diagnostic methods and immunization method

### DEFINITIONS

- define polypeptide
- describe polypeptide modifications
- introduce substantially pure polypeptide fragment
- define Chlamydia species
- describe MOMP of C. trachomatis
- explain T celle epitopes and human antibody response
- define Chlamydia patient
- describe delayed type hypersensitivity reaction
- introduce IFNγ
- define nucleic acid fragment and sequence
- describe sequence identity calculation
- introduce minimum percentage of sequence identity
- define immunogenic portion
- describe T-cell epitopes identification
- introduce B-cell epitopes determination
- describe immunogenic portion length
- define variants of polypeptides
- define immune individual
- define immunogenic polypeptide

### Preparation Methods

- prepare C. trachomatis antigens and DNA sequences

### Fusion Proteins

- produce immunogenic polypeptides as fusion proteins
- enhance immunogenicity with fusion partners

### Pharmaceutical Composition

- define pharmaceutical composition

### Vaccine, Protein

- describe vaccine composition
- ensure optimum performance with carrier, vehicle, or adjuvant
- select suitable carriers, vehicles, and adjuvants
- prepare vaccines with peptide sequences
- achieve adjuvant effect with various methods
- administer vaccines in various formulations and routes
- describe multiple administrations and vaccine compositions

### Vaccine DNA.

- use nucleic acid fragments for DNA vaccines

### Live Recombinant Vaccines

- express antigens in non-pathogenic microorganisms or viruses

### Therapeutic Vaccine.

- use polypeptide or nucleic acid for therapeutic vaccines

### Diagnostic Protein

- define diagnostic method for Chlamydia infection
- describe skin response indicative of infection
- outline in vitro method for diagnosing ongoing or previous sensitisation
- specify immunogenic composition for diagnosing
- introduce diagnostic DNA
- describe method of determining presence of chlamydial nucleic acids
- outline PCR technique for diagnosing Chlamydia infection
- introduce antibodies
- describe production of monoclonal or polyclonal antibodies
- outline method for producing antibodies
- describe diagnostic use of antibodies
- summarize antigenic components of C. trachomatis

## EXAMPLES

### Example 1

- introduce C. trachomatis serovar D
- describe microorganism and cultivation
- harvest C. trachomatis
- prepare C. trachomatis lysate for fractionation
- fractionate C. trachomatis lysate
- analyze fractions by mass spectrometry
- prepare lymphocytes and cell culture
- stimulate lymphocytes with antigens
- measure IFNγ response
- identify recombinant C. trachomatis antigens
- test recognition of recombinant proteins
- map fine specificity of T cell response to CT521

### Example 2

- introduce directed library strategy
- construct full-length library of C. trachomatis genes
- express and screen library with patient serum
- identify positive clones by colony blot
- confirm positive clones by Western blot

### Example 3

- introduce random library strategy
- isolate high molecular weight C. trachomatis serovar D genomic DNA
- construct whole-C. trachomatis-genome random expression library
- screen library with patient pool serum
- identify immunoreactive plaques and sequence DNA
- analyze sequences and identify CT antigens
- generate phage stocks and sequence individual plaques
- summarize results of library screening

### Example 5

- construct recombinant adenovirus encoding C. trachomatis antigens
- test adenovirus stocks and measure T-cell response

### Example 6

- introduce rodent protection strategy
- describe animal model and immunization protocol
- prepare C. muridarum stock
- infect mice and monitor infection
- immunize mice with peptide vaccines
- evaluate immune response by lymphocyte cultures and serum antibodies
- test vaccine candidates for IFN-γ response and serum reactivity
- evaluate protective efficacy of vaccine candidates
- summarize results of rodent protection strategy

### Example 7

- introduce whole-genome random expression library
- screen for C. trachomatis specific T-cell epitope targets

### Example 8

- test antigens for T-cell recognition

### Example 9

- map antibody targets using purified antigens

### Example 10

- describe protection strategy in C3H/HeN mice
- immunize mice with antigens and evaluate immune response
- evaluate protective efficacy of vaccine candidates

